Thanks to its non-destructive analysis capabilities, Bruker's X4 Poseidon imaging platform is ideally suited for pharmaceutical development and quality control. This benchtop 3D X-ray microscope enables non-destructive analysis of both the outer capsule and its contents using a high-resolution 3D dataset. The image shown here was scanned at a voxel size of 3.5 µm in just 26 minutes.
Brian Metscher from the Institute of Evolutionary Biology at the University of Vienna provided us with three samples to test the quality of the X4 Poseidon at high magnifications. We were just as impressed with the images as he was.
Our team succeeded in developing a protection concept for the sensitive materials of the solid-state battery. This made it possible to scan the electrode structure with submicrometer resolution over many hours.
Intraoperative margin assessment using X-rays has long been standard in breast cancer treatment in countries such as the USA, China, Japan, and the UK. Although the procedure can significantly reduce the number of repeat surgeries, the technology has been adopted only hesitantly in Germany.
Bruker has achieved a great success with the X4 POSEIDON. With this system, Bruker is introducing a platform for 3D X-ray microscopy or microtomography in table format, which can be equipped with various sources and detectors depending on the customer's requirements.
As part of the DELFIN joint project, we have acquired a new type of X-ray microscope (“nano-CT”) to examine the electrode structure of a modern lithium solid-state battery using 3D imaging.
In addition to our daily analysis work, researching and developing new processes is particularly exciting for us. We are therefore very pleased that we are able to work on the DELFIN joint project and thus on an interesting topic - the development of solid-state batteries.
Our customer Dr. Anton Windfelder from the Justus Liebig University of Giessen has published an impressive study on the intestinal tract of the tobacco hornworm caterpillar (Manduca sexta). This animal serves as a model system for ecotoxicology, immunology and intestinal physiology.
In the Bruker AXS webinar series, our managing director Dr.-Ing. Markus J. Heneka spoke as an expert about the application of 3D X-ray tomography in the pharmaceutical industry. The event was viewed very positively by well over 100 registered participants from all over the world.
